# US 2026/0144815 A1 · Blood coagulation time shortening agent for blood specimen deficient in coagulation factor xii

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0144815 A1
- Document ID: US20260144815A1
- Status: Published application
- Kind: A1
- Application number: 19/120,018
- Filed: 2023-10-13
- Published: 2026-05-28
- Earliest claimed: 2022-10-14
- Assignees: Sekisui Medical Co., Ltd.
- Applicants: Sekisui Medical Co., Ltd.
- Inventors: Mitsuaki YAMAMOTO; Yoshimasa BANBA; Ryousuke HORIUCHI; Satoshi MACHIDA
- Web page: https://patentgrep.com/patent/US20260144815A1

## CPC

- A61K 31/80: Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 31/37: Coumarins, e.g. psoralen
- A61K 31/401: Proline; Derivatives thereof, e.g. captopril
- A61K 31/785: Polymers containing nitrogen
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61K 33/24: Heavy metals; Compounds thereof
- A61K 33/26: Iron; Compounds thereof
- A61K 33/30: Zinc; Compounds thereof
- A61K 33/32: Manganese; Compounds thereof
- A61K 33/34: Copper; Compounds thereof
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 7/04: Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- G01N 33/86: involving blood coagulating time {or factors, or their receptors}
- C08F 230/02: containing phosphorus
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS

## Abstract

A blood coagulation time shortening agent for a blood specimen deficient in coagulation factor XII, in activated partial thromboplastin time measurement includes, as an active ingredient, a polymer having 2-methacryloyloxyethyl phosphorylcholine as a constitutional unit.

## Claims

### Claim 1

A blood coagulation time shortening agent for a blood specimen deficient in coagulation factor XII, in activated partial thromboplastin time measurement, comprising a polymer having 2-methacryloyloxyethyl phosphorylcholine as a constitutional unit and an amino acid.

### Claim 2 (depends on 1)

The shortening agent according to claim 1, wherein the polymer is a copolymer of 2-methacryloyloxyethyl phosphorylcholine and another monomer having a hydrophobic group, an anionic group, or a cationic group.

### Claim 3 (depends on 2)

The shortening agent according to claim 2, wherein the copolymer has a surface tension of from 44×10−3 to 66×10−3 N/m in a 0.1 wt % aqueous solution at 25° C. and a kinematic viscosity of from 0.5 to 6 m2/s in a 5 wt % aqueous solution at 25° C., or has a surface tension of from 70×10−3 to 75×10−3 N/m in a 0.1 wt % aqueous solution at 25° C. and a kinematic viscosity of from 2 to 7.3 m2/s in a 5 wt % aqueous solution at 25° C.

### Claim 4 (depends on 1)

The shortening agent according to claim 1, further comprising a metal salt.

### Claim 5 (depends on 4)

The shortening agent according to claim 4, wherein the metal salt compound is at least one selected from the group consisting of yttrium chloride, iron (III) chloride, aluminum chloride, indium (III) chloride, copper chloride, potassium aluminum sulfate, ammonium iron (III) sulfate, copper sulfate, zinc chloride, manganese chloride, and hydrates thereof.

### Claim 6 (depends on 1)

The shortening agent according to claim 1, wherein the amino acid is at least one selected from the group consisting of α-alanine, arginine, asparagine, aspartic acid, glutamic acid, glycine, glycylglycine, methionine, phenylalanine, proline, serine, threonine, valine, and tricine.

### Claim 7 (depends on 1)

An activated partial thromboplastin time measurement reagent comprising the blood coagulation time shortening agent according to claim 1.

### Claim 8 (depends on 1)

An activated partial thromboplastin time measurement method comprising measuring a blood coagulation time of a sample solution containing a blood specimen and the blood coagulation time shortening agent according to claim 1.

### Claim 9 (depends on 1)

A method for shortening blood coagulation time of a blood specimen deficient in coagulation factor XII in activated partial thromboplastin time measurement, comprising measuring blood coagulation time of a sample solution containing the blood specimen and the blood coagulation time shortening agent according claim 1.

### Claim at position 10

10-15. (canceled)
